United States· US:31722-100_4729e7ee-3333-ee2b-e063-6394a90aa85c
Nitazoxanide
A nitazoxanide product containing nitazoxanide, registered in United States by Camber Pharmaceuticals, Inc.. The same ATC class is registered in 3 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Nitazoxanide is registered in 3 of 19 countries.
Countries holding a registration under ATC P01AX11 (nitazoxanide), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Nitazoxanide · ATC P01AX11
3 / 19 countries
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- NITAZOXANIDE
- Manufacturer
- Camber Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- P01AX11
- ATC class
- Nitazoxanide
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc1131722100301 BOTTLE in 1 CARTON (31722-100-30) / 30 TABLET, FILM COATED in 1 BOTTLE
- ndc1131722100311 BOTTLE in 1 CARTON (31722-100-31) / 12 TABLET, FILM COATED in 1 BOTTLE
- ndc1131722100321 BOTTLE in 1 CARTON (31722-100-32) / 6 TABLET, FILM COATED in 1 BOTTLE
- ndc1131722-100-30
- ndc1131722-100-31
- ndc1131722-100-32
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
27 interactions on record for nitazoxanide.
Graded by severity as the source publishes them — 27 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nitazoxanide · interactions on record
27 records
- 27 moderate
Most severe, free to view
- GlibenclamideA10BB01moderate
- ChlorpropamideA10BB02moderate
- TolbutamideA10BB03moderate
- TolazamideA10BB05moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Nitazoxanide in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eae27177-4183-4bfd-9087-0da1c3c18538 GET /v1/drugs/eae27177-4183-4bfd-9087-0da1c3c18538?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "500",
"substance": "NITAZOXANIDE",
"productndc": "31722-100",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA218701",
"marketing_category": "ANDA"
}See everything about nitazoxanide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.